These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6265707)

  • 1. Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix.
    Lüleci G; Sakizli M; Günalp A; Erkan I; Remzi D
    J Surg Oncol; 1981; 16(4):327-31. PubMed ID: 6265707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
    Murphy JF; Murphy DF; Barker S; Mylotte ML; Coughlan BM; Skinner GR
    Med Microbiol Immunol; 1985; 174(2):73-80. PubMed ID: 2993833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 2 and cancer of the prostate.
    Herbert JT; Birkhoff JD; Feorino PM; Caldwell GG
    J Urol; 1976 Nov; 116(5):611-2. PubMed ID: 62063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
    Kawana T; Yoshino K; Kasamatsu T
    Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer: patterns of neutralizing antibodies.
    Christenson B; Espmark A
    Am J Epidemiol; 1977 Apr; 105(4):296-302. PubMed ID: 192072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to simian vacuolating virus 40 in bladder cancer patients.
    Bravo MP; del Rey-Calero J; Olivares I; Vizcaino MJ
    Urol Int; 1987; 42(6):427-30. PubMed ID: 2834853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Herpes simplex virus type 2 and cervix cancer].
    te Velde ER; The TH
    Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1226-30. PubMed ID: 209356
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiological role of the herpes simplex virus in causing cervical cancer].
    Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
    Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological studies against herpes simplex virus types I & II in cervical carcinoma patients.
    Rajeswari N; Thyagarajan SP; Kanaklata ; Rajendran P; Subramanian S; Vaideeswaran ; Shanta V
    Indian J Pathol Microbiol; 1987 Apr; 30(2):157-62. PubMed ID: 2856216
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 19. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
    Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
    Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
    Seth P; Prakash SS; Ghosh D
    Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.